共 50 条
- [32] Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (06):
- [33] Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 316 - 318
- [35] Short-term Androgen-Deprivation Therapy Improves Prostate Cancer-Specific Mortality in Intermediate-Risk Prostate Cancer Patients Undergoing Dose-Escalated External Beam Radiation Therapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (04): : 1012 - 1017
- [36] Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy JOURNAL OF UROLOGY, 2022, 207 (06): : 1227 - 1234
- [40] PREDICTORS OF PROSTATE CANCER SPECIFIC MORTALITY IN ELDERLY MEN WITH INTERMEDIATE-RISK PROSTATE CANCER TREATED WITH BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION THERAPY INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 147 - 152